| Product Code: ETC8630493 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The non-cardioselective beta blockers import market in Nigeria continues to be dominated by key exporting countries such as India, China, Netherlands, Metropolitan France, and the USA in 2024. Despite a significant negative compound annual growth rate (CAGR) of -26.13% from 2020 to 2024, the market experienced a further decline with a growth rate of -30.33% from 2023 to 2024. The high concentration of the Herfindahl-Hirschman Index (HHI) indicates a competitive market landscape with room for potential shifts in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Non-Cardioselective Beta Blockers Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, 2022 & 2032F |
3.3 Nigeria Non-Cardioselective Beta Blockers Market - Industry Life Cycle |
3.4 Nigeria Non-Cardioselective Beta Blockers Market - Porter's Five Forces |
3.5 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume Share, By Target, 2022 & 2032F |
3.7 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume Share, By Drugs, 2022 & 2032F |
3.8 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.9 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.10 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Nigeria Non-Cardioselective Beta Blockers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Nigeria |
4.2.2 Growing awareness about the benefits of non-cardioselective beta blockers in managing heart conditions |
4.2.3 Rising healthcare expenditure and improving access to healthcare services in the country |
4.3 Market Restraints |
4.3.1 Limited availability and affordability of non-cardioselective beta blockers in rural areas |
4.3.2 Lack of skilled healthcare professionals to prescribe and administer these medications effectively |
5 Nigeria Non-Cardioselective Beta Blockers Market Trends |
6 Nigeria Non-Cardioselective Beta Blockers Market, By Types |
6.1 Nigeria Non-Cardioselective Beta Blockers Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Indication, 2022 - 2032F |
6.1.3 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Angina, 2022 - 2032F |
6.1.4 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Hypertension, 2022 - 2032F |
6.1.5 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Heart Failure, 2022 - 2032F |
6.1.6 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Arrhythmias, 2022 - 2032F |
6.1.7 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 Nigeria Non-Cardioselective Beta Blockers Market, By Target |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Beta-1 Receptors, 2022 - 2032F |
6.2.3 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Beta-2 Receptors, 2022 - 2032F |
6.2.4 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 Nigeria Non-Cardioselective Beta Blockers Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Propranolol, 2022 - 2032F |
6.3.3 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Nadolol, 2022 - 2032F |
6.3.4 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Labetalol, 2022 - 2032F |
6.3.5 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Carvedilol, 2022 - 2032F |
6.3.6 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Sotalol, 2022 - 2032F |
6.3.7 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Timolol, 2022 - 2032F |
6.3.8 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2022 - 2032F |
6.3.9 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 Nigeria Non-Cardioselective Beta Blockers Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Oral, 2022 - 2032F |
6.4.3 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Parenteral, 2022 - 2032F |
6.4.4 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2022 - 2032F |
6.5 Nigeria Non-Cardioselective Beta Blockers Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.5.3 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Homecare, 2022 - 2032F |
6.5.4 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.5.5 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2022 - 2032F |
6.6 Nigeria Non-Cardioselective Beta Blockers Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
6.6.3 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Online Pharmacy, 2022 - 2032F |
6.6.4 Nigeria Non-Cardioselective Beta Blockers Market Revenues & Volume, By Retail Pharmacy, 2022 - 2032F |
7 Nigeria Non-Cardioselective Beta Blockers Market Import-Export Trade Statistics |
7.1 Nigeria Non-Cardioselective Beta Blockers Market Export to Major Countries |
7.2 Nigeria Non-Cardioselective Beta Blockers Market Imports from Major Countries |
8 Nigeria Non-Cardioselective Beta Blockers Market Key Performance Indicators |
8.1 Number of new patients prescribed non-cardioselective beta blockers |
8.2 Percentage increase in the usage of non-cardioselective beta blockers in hospitals and clinics |
8.3 Average prescription duration for non-cardioselective beta blockers |
9 Nigeria Non-Cardioselective Beta Blockers Market - Opportunity Assessment |
9.1 Nigeria Non-Cardioselective Beta Blockers Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 Nigeria Non-Cardioselective Beta Blockers Market Opportunity Assessment, By Target, 2022 & 2032F |
9.3 Nigeria Non-Cardioselective Beta Blockers Market Opportunity Assessment, By Drugs, 2022 & 2032F |
9.4 Nigeria Non-Cardioselective Beta Blockers Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.5 Nigeria Non-Cardioselective Beta Blockers Market Opportunity Assessment, By End User, 2022 & 2032F |
9.6 Nigeria Non-Cardioselective Beta Blockers Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Nigeria Non-Cardioselective Beta Blockers Market - Competitive Landscape |
10.1 Nigeria Non-Cardioselective Beta Blockers Market Revenue Share, By Companies, 2025 |
10.2 Nigeria Non-Cardioselective Beta Blockers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here